
Tamsuvians 0.4mg Tablet MR
Marketer
Vivichem Pharma
Salt Composition
Tamsulosin (0.4mg)
Overview Tamsuvians 0.4mg Tablet MR
Tamsulosin 0.4mg modified-release tablets are an alpha-blocker employed in managing benign prostatic hyperplasia (BPH). This medication alleviates urinary symptoms such as hesitancy, but doesn't reduce prostate volume. Always adhere to your physician's prescribed dosage and duration. Consumption with or without food is acceptable, but maintain consistent timing. Swallow the tablet whole; avoid crushing or chewing. Discontinuation requires medical consultation, as abrupt cessation may exacerbate symptoms. Complete the prescribed course for optimal therapeutic benefit. Common side effects may include lightheadedness, back discomfort, chest pain, altered ejaculation, and retrograde ejaculation. Persistent or bothersome side effects warrant immediate medical attention. Lifestyle adjustments can aid symptom management. Void upon experiencing the urge, but avoid straining. Limit evening and pre-sleep consumption of caffeine and alcohol. Prior to treatment, disclose all current medications and health conditions to your doctor. If cataract or glaucoma surgery is planned, inform your ophthalmologist about Tamsulosin use. Individuals with liver impairment should exercise caution, with regular monitoring by their doctor.
Uses of Tamsuvians 0.4mg Tablet MR
Managing benign prostatic enlargement
Major Benefits of Tamsuvians 0.4mg Tablet MR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 0.4mg Tamsuvians MR tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
Common Side effects of Tamsuvians 0.4mg Tablet MR:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Tamsuvians 0.4mg Tablet MR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Tamsuvians 0.4mg Modified-Release Tablets can be consumed with or without food, although consistent daily timing is recommended.
How Tamsuvians 0.4mg Tablet MR works:
Tamsulosin 0.4mg modified-release tablets are alpha-adrenergic antagonists. Their mechanism of action involves relaxing bladder neck and prostate muscles, facilitating improved urinary flow. This promotes complete bladder emptying and lessens the frequency and urgency of urination associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Tamsuvians 0.4mg modified-release tablets and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on the use of 0.4mg modified-release Tamsulosin tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Tamsuvians 0.4mg Tablet MR while breastfeeding is likely unsafe. Available data in humans indicates potential transfer to breast milk, posing a risk to the infant. This medication is contraindicated in lactating women.
DrivingSAFE
Driving ability is typically unaffected by Tamsuvians 0.4mg MR tablets.
KidneySAFE IF PRESCRIBED
Tamsuvians 0.4mg Tablet MR presents a safe profile for individuals with kidney impairment, requiring no dosage modification. Data regarding its use in patients with end-stage renal disease remains scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Tamsuvians 0.4mg Tablet MR cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tamsuvians 0.4mg Tablet MR :
Should you forget a Tamsuvians 0.4mg MR Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tamsuvians 0.4mg Tablet MR
| Label | Value |
|---|---|
| Chemical Type | Sulfamide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
